1 Min Read
June 6 (Reuters) - BASILEA PHARMACEUTICA AG:
* ANNOUNCES PRESENTATION OF INTERIM PHASE 1/2A CLINICAL DATA WITH ANTICANCER DRUG CANDIDATE BAL101553 AT ASCO MEETING Source text for Eikon: Further company coverage: (Gdynia Newsroom)
All quotes delayed a minimum of 15 minutes. See here for a complete list of exchanges and delays.
© 2017 Reuters. All Rights Reserved.